The cyclin-dependent kinase inhibitor p16 (p16 INK4A / CDKN2/MTS1) is a potent inhibitor of the cyclin Ddependent phosphorylation of the retinoblastoma gene (Rb) product, the inactivation of which induces loss of Rb-dependent G1 arrest through inappropriate phosphorylation of the Rb protein. INK4A protein expression with immunohistochemistry, deletions of the gene by FISH, and determined the methylation status of exon 1a using a PCR-based methylation assay. Finally, possible mutations were studied by SSCP and subsequent sequencing. Twenty one of the 43 (49%) NSCLC studied exhibited an absence of p16 INK4A nuclear staining. Of these, three (14%) had frameshift or missense mutations, seven (33%) displayed methylation of exon1a and 10 (48%) displayed homozygous deletions. In total, 95% of the tumors with p16
protein expression to genetic or epigenetic mechanisms, we have performed a comprehensive study of p16 status in a series of 43 NSCLC. To this end, we have investigated p16
INK4A protein expression with immunohistochemistry, deletions of the gene by FISH, and determined the methylation status of exon 1a using a PCR-based methylation assay. Finally, possible mutations were studied by SSCP and subsequent sequencing. Twenty one of the 43 (49%) NSCLC studied exhibited an absence of p16 INK4A nuclear staining. Of these, three (14%) had frameshift or missense mutations, seven (33%) displayed methylation of exon1a and 10 (48%) displayed homozygous deletions. In total, 95% of the tumors with p16
INK4A negative staining carried one of these three alternative genetic or epigenetic alterations. Furthermore, a high degree of chromosome 9 polysomy was found (58%) in those tumors with p16 INK4A inactivation. Taken together these results suggest that deregulation of the p16 gene locus is a frequently occurring event in NSCLC through distinct mechanisms including rare point mutations, promotor methylation and frequent homozygous deletions. Furthermore, our data show that immunohistochemistry is a rapid and an accurate technique for screening of p16
Introduction
The cyclin-dependent kinase (CDK) inhibitor p16 (p16 INK4A /CDKN2/MTS1) (Serrano et al., 1993) is an important component of cell cycle regulation. The p16
INK4A gene encodes a cell cycle protein, which is a potent inhibitor of CDK4 and CDK6 (Serrano et al., 1993 , for a review, see Sherr, 1996) and negatively regulates the cyclin D-dependent phosphorylation of the retinoblastoma gene product, thereby inhibiting cell cycle progression from G1 to S-phase by sequestration of E2F (Lukas et al., 1995) . Other reports have provided evidence that the p16 INK4A levels may be regulated by Rb protein Tam et al., 1994) , suggesting that Rb participates in a feedback loop to limit the levels of p16 INK4A . Genetic alterations of p16 INK4A , leading to its inactivation in tumors, results in the deregulation of cell proliferation through loss of G1 arrest control. Accumulating evidence implicates p16
INK4A as a tumor suppressor gene in tumorigenesis. p16
INK4A maps to 9p21, a chromosomal locus frequently altered in many primary tumors and cell lines (Hussussian et al., 1994; Nobori et al., 1994; Kamb et al., 1994; Okamoto et al., 1994) . Homozygous deletions, inactiving mutations and, more recently, methylation at the 5' CpG island associated with transcriptional silencing have been identi®ed as alternative mechanisms of p16 INK4A inactivation (Cairns et al., 1994 (Cairns et al., , 1995 Merlo et al., 1995) . Furthermore, ectopic expression of wild-type p16
INK4A in some tumor cell lines leads to G1 arrest and growth inhibition (Jin et al., 1995; Liggett et al., 1996; Spillare et al., 1996) . Moreover the eects of p16 INK4A require a functional Rb, suggesting the existence of a common p16
INK4A
/Rb growth suppressor pathway (Koh et al., 1995; Guan et al., 1994; Liggett et al., 1996; Lukas et al., 1995) . The redundancy of Rb and p16
inactivation on this common pathway is supported by the observation of an inverse correlation between alterations in the expression of both proteins in several tumors types (Okamoto et al., 1994; Otterson et al., 1994; Geradts et al., 1995; Tam et al., 1994; Shapiro et al., 1995; Kelley et al., 1995) . The notion of a feedback regulation of p16 INK4A by Rb is consistent with the accumulation of high levels of p16
INK4A mRNA in cells lacking Rb function .
In human lung cancer, p16 INK4A aberrations are frequent Okamoto et al., 1994; Kratzke et al., 1996; Sakaguchi et al., 1996) . Homozygous deletions have been described in lung tumors, with a highly variable frequency (9 ± 25%). They were more frequently detected in cell lines (Kamb et al., 1994; Nobori et al., 1994) than in fresh tumor tissue (Cairns et al., 1995; Packenham et al., 1995; De Vos et al., 1995; Marchetti et al., 1997; Wiest et al., 1997) probably due to stromal contamination of the tumoral samples. Methylation of the 5' CpG island associated with transcriptional silencing has been investigated in only one study of primary lung tumors where its incidence was 26% . p16
INK4A mutations are less common (0 ± 8%) Cairns et al., 1994; Rusin et al., 1996; Okamoto et al., 1995) except for one study reporting 30% of intragenic mutations (Hayashi et al., 1994) . To date, the real prevalence of these three known mechanisms (i.e. homozygous deletion, methylation and mutation) in p16 INK4A sequencing did not reveal any mutation thus excluding a polymorphism in these two cases. The last tumor carrying a missense mutation (T29) did not express p16
INK4A protein on the basis of IHC analysis but displayed de novo methylation of exon1a as described below. We could not exclude a polymorphism in this last case since normal lung was not available.
p16
INK4A methylation status A PCR-based methylation assay was performed in the same series of tumors using methylation-sensitive endonucleases for DNA cleavage in exon 1 of p16
INK4A
(CfoI, HpaII, SmaI, SacII), followed by PCR amplification of the digested DNAs. Two tumors (T29, T39) showed methylation with all four restriction enzymes used, one tumor (T42) with three enzymes (CfoI, SacII, HpaII) and the four others (T14, T18, T28, T32), with only one enzyme (SmaI for T14, SacII for T18 and T32 and CfoI for T28) (Table 3) . Normal lung tissue was available in ®ve of these seven patients (T18, T29, T32, T39, T42) and DNA hypermethylation was never observed in these normal tissues. Overall, patterns consistent with partial or total methylation were observed in seven of the 21 (33%) lung tumors displaying absence of p16 INK4A staining and were never found in the tumors with positive p16
INK4A immunostaining (Table 3 ). It should be noted that all the histological types of NSCLC examined were aected by methylation: 33% of squamous carcinoma, 25% of adenocarcinoma and 40% of basal cell carcinoma. Figure 3 shows representative examples of the 43 lung cancer cases examined, from which normal lung and the corresponding lung tumor were available. The methylation status at SmaI and SacII restriction sites was also analysed by Southern blotting in the seven tumors with abnormal methylation status and the results were concordant with those of the PCR methylation assay. 
FISH analysis
To address the molecular status of the p16 INK4A -protein negative tumors (by IHC) for which mutations or de novo methylation of p16 INK4A were not detected (12 cases), a FISH analysis was performed on touch preparations of tumor material. Initial examination of normal bronchial epithelia showed an hybridization eciency of more than 95%. Hybridization was successful on all 12 malignant neoplasms studied. One hundred nuclei were analysed for each touch preparation. Unexpectedly, seven of the 12 tumors studied (58%) carried three or more copies of chromosome 9, revealing a high degree of chromosome 9 instability in the tumors analysed in this study (Table 4) . This instability was not related to the stage of the tumors. Homozygous deletion of the p16
INK4A locus was assessed when no visible signal could be detected with the p16 INK4A probe whereas one, two or more positive signals were revealed by the centromeric probe. Absence of any p16
INK4A signal was found at a high frequency in the tumor cells of 10 of the 12 tumors analysed, indicating an homozygous deletion of the p16 INK4A chromosomal locus (Table 4) . A particular pattern was observed in the two remaining tumors. For tumor T43, no p16
INK4A signal was observed in only 10% of the nuclei and we did not consider this case as homozygously deleted. However, the persistence of only one signal for p16
INK4A in the majority of the nuclei analysed was typical of a loss of heterozygosity at the p16 INK4A locus in this tumor. On the other hand, in tumor T19 a very high degree of chromosome 9 polysomy was detected as 97% of the nuclei had more than two copies of chromosome 9 with more than 50% of them containing four, ®ve or six copies of chromosome 9. Despite the absence of homozygous deletions of p16 INK4A in those two cases, we considered them as genetically altered.
In total homozygous deletions were found in 4/7 adenocarcinomas (57%), 5/9 squamous carcinomas (56%) and in 1/5 basal cell carcinoma (20%). Overall, 48% (10/21) of the tumors with p16 INK4A negative staining had an homozygous deletion. Examples of the FISH analysis for homozygous deletion and chromosome 9 polysomy are presented in Figure 4 .
Correlation between IHC and molecular analyses T13  T15  T16  T17  T19  T27  T31  T33  T34  T35  T40  T43   94  64  34  9  97  9  39  45  9  46  4  6   80  84  43  71  0  82  46  82  73 in the carcinogenic process of human NSCLC (Kratzke et al., 1996; Sakaguchi et al., 1996; Geradts et al., 1995) . However, discrepancies between the reactivities of the two p16
INK4A antibodies used were detected in 16% of the cases, indicating that care must be taken in interpreting both positive and negative immunostaining specially with p16 INK4 antibody. T1  T2  T3  T4  T5  T6  T7  T8  T9  T10  T11  T12  T13  T14  T15  T16  T17  T18  T19  T20  T21  T22  T23  T24  T25  T26  T27  T28  T29  T30  T31  T32  T33  T34  T35  T36  T37  T38  T39  T40  T41  T42 ADK, adenocarcinoma, Sq, squamous carcinoma, Bas. Cell, basal cell carcinoma, nd, not down, Absent (7), Present (+). RB staining was previously performed using F8, PMG3 245 and RBA1 (C36) RB antibodies as described in Gouyer et al. (1994) 
Loss of p16
INK4A expression in many tumors can be accounted for by either homozygous deletions or hypermethylations or mutations (Cairns et al., 1994 (Cairns et al., , 1995 Merlo et al., 1995) . Although these three alternative mechanisms have been described in lung cancer, they had never been assessed simultaneously in a single tumor series and in comparison with the actual status of the p16 INK4A protein expression. Previous reports have described an increased frequency of p16 alterations in late stages or at metastatic sites over primary tumor sites Okamoto et al., 1995; Nakagawa et al., 1995; Kratzke et al., 1996; Marchetti et al., 1997) . In contrast, we have not observed a dierence in the distribution of p16 INK4A genetic or epigenetic abnormalities as a function of disease stage or between tumors from primary or metastatic sites.
On the basis of our genetic analysis, we have shown that IHC is a straightforward method to detect p16 INK4A inactivation. Indeed, our results demonstrate a high correlation between IHC and genetic analysis since homozygous deletions, methylations or frameshift mutations were observed in nearly all of immunohistochemical negative cases. By referring to our criteria of analysis and taking a 10% threshold value for positive nuclei, IHC appears to be a rapid and reliable method for studying the inactivation of p16 INK4A in lung tumors. In this respect, our results are supported by a recent report on primary head and neck squamous cell carcinoma where the same approach was used. This study also showed a high correlation between IHC results and those of genetic analysis (Reed et al., 1996) .
Although we detected all known mechanisms of genetic or epigenetic inactivation of p16 INK4A , it is important to note than in four tumors studied here, missense mutations which were not polymorphisms neither created stop codons, nor impaired C-terminal epitope recognition by antibodies. Both missense mutation and DNA methylation were detected in one of these tumors. Since methylation in exon 1 of p16 INK4A leads to gene silencing one possibility is that p16
INK4A negative immunostaining could be due to methylation in this case. An alternative transcript for p16 (p16b) which consists of a distinct exon 1 (exon 1b) spliced onto the remaining exons 2 and 3 of p16 has recently been reported Duro et al., 1995; Stone et al., 1995) . Because of a shift in the ORF, the b transcript theoretically encodes a protein that is structurally distinct from p16 INK4A protein. Indeed, the presence of a similar alternative transcript encoding a p19 IARF protein has been reported in mouse cells (Quelle et al., 1995) . A human p19 IARF protein has also been characterized in various cells including normal ®broblasts (Larsen, personal communication) .
Because of the existence of the alternate protein, we supposed that the mutation we found in tumor T29 had no eect on p16
INK4A inactivation but could alter the reading frame and the function of the p19 IARF protein. It should be noted that the same mutation at codon 57 has been previously described in acute lymphoblastic leukaemia (Qesnel et al., 1995) . The three other missense mutations have not been previously described. However two of them are located at codons 74 and 83 which were previously reported as targets of mutations in various tumors (Pollock et al., 1996) . The eect of these mutations on p16
INK4A function is unclear since p16 INK4A was expressed. Nevertheless some missense mutations, including a C to T transition at codon 83, have been shown to encode a functionally inactive protein (Koh, 1995; Shapiro et al., 1995; Arap et al., 1995) . Furthermore the fact that RB protein was expressed in all these three tumors suggests that the p16 INK4A missense mutations are functionally inactivating. Thus only a functional study of the protein encoded by these mutant genes could classify them as inactivating mutations of p16 INK4A gene. However, again we cannot exclude the potential eect of some of these mutations on the alternate reading frame of a p19
IARF . Two tumors displayed absence of IHC staining for p16
INK4A without any obvious genetic or epigenetic alteration. Analysis of mRNA expression by Northern blotting revealed an apparently normal mRNA expression (data not shown). Beside an unusual possibility of IHC false negative results, we cannot exclude the possibility that mutations could have been missed by SSCP, or that a yet undetermined mechanism of genetic or epigenetic inactivation occurred in these cases.
Our results demonstrate a major implication of the homozygous deletion in the inactivation of p16 INK4A in NSCLC. They also indicate the importance of the technique chosen for this analysis. Indeed, FISH is the most reliable method to discriminate between normal and tumoral cells. Furthermore we found an apparent clonal out-growth of cells showing three or more chromosome 9 copies which indicates a high degree of chromosome 9 polysomy in these tumors, probably re¯ecting a generalized chromosomal instability as has previously been reported in bronchial metaplasia (Hittelman et al., 1996) .
In conclusion, we believe that the immunohistochemical test we described here is a suitable approach to screen rapidly for p16
INK4A abnormalities in fresh-frozen tissue. Methods are now available for application to formalin-®xed paran sections. However, although negative immunostaining of p16
INK4A is a strong indication for the presence of one of the three genetic or epigenetic above mentioned abnormalities leading to p16
INK4A inactivation, great care must be taken in the interpretation of positive nuclear reactivity which may not necessarily indicate the presence of functional p16 INK4A in some tumors.
Materials and methods

Tissue samples
Forty-three lung tumors were included in this study. In 36 cases, sample was obtained at surgery, and in the remaining cases at mediastinoscopy (six mediastinal lymph node metastasis and one bone metastasis). Samples were immediately frozen at surgery and kept at 7808C until study.
For histological classi®cation, tumor samples were ®xed in formalin and/or alcoholic Bouin's ®xative. The study included 19 adenocarcinoma, 16 squamous carcinoma p16 INK4A inactivation in lung cancer S Gazzeri et al according to WHO classi®cation (1981) and eight basaloid carcinoma considered as basal stem cell proliferation according to Brambilla et al. (1992) .
Immunohistochemistry
p16
INK4A immunostaining was performed on frozen sections ®xed with 4% paraformaldehyde using classical immunoperoxidase techniques. Two polyclonal antibodies were used: p16 INK4A (1/500) (Pharmingen, CA) and p16 C-20 (Santa-Cruz, CA). After overnight incubation at 48C with the primary antibody, slides were washed in phosphatebuered saline (PBS) and then exposed to the secondary antibody, biotinylated donkey F(ab') 2 anti-rabbit (1/1000; Kackson Laboratories, West Grove, PA) for 1 h at room temperature. They were then washed in PBS and incubated with the streptavidine-biotin-peroxidase complex (1/400; Dako) for 1 h at room temperature. The chromogenic substrate of peroxidase was a solution of 0.05% 3.3-diaminobenzidine tetrahydrochloride/0.03% H 2 O 2 / 10 mmol/l, imidazole on 0.05 mol/l tris buer, pH 7.6. The slides were counterstained with Harris' hematoxylin. Normal rabbit IgG at the same concentration as the primary antibodies served as negative controls.
SSCP analysis and sequencing
Genomic DNA was extracted from fresh frozen tissues using standard methods. 100 ng of genomic DNA was ampli®ed in a total volume of 20 ml in a buer containing 8 pmol of sense and antisense primers, 200 mM of each dNTP, 16ampli®cation buer, 1.5 mM MgCl 2 , 5% of dimethylsulfoxide, 2 mCi [a 33 P]dATP and 2.5 units of Taq polymerase (Promega).
Primers for exon 1 of p16
INK4A
gene were (5'-3'): GAGAGGGGGAGAGCAGGCAG (sense); GCAAACT-TCGTCCTCCAGAGT (anti-sense). Primers for exon 2 of p16 INK4A gene were (5'-3'): GCTCTACACAAGCTTCCTTTC (sense); TGAGCTTTGGAAGCTCT (anti-sense). PCR conditions used to amplify exons 1 and 2 of the p16 INK4A gene were: one cycle at 948C for 5 min; 30 cycles at 948C (1 min), 608C (1 min) and 728C (1 min) each, and a ®nal extension at 728C for 10 min.
The PCR product (4 ml) was diluted twofold with a buer containing 50% formamide, heat-denatured and applied to a 6% neutral polyacrylamide gel in presence of 2% glycerol. For exon 2, the PCR products were digested overnight with SmaI (2.5 U per 10 ml) before denaturation and loading on the gel. The cases with mobility shift were cloned in a pTag vector (pUC backbone derived) using the Ligator Kit (Ingenius) and sequenced using the sequenase sequencing kit (USB).
PCR-based methylation assay
The methylation status of genomic DNA was analysed using the modi®ed PCR methylation assay (GonzalezZulueta, 1995) . One mg of genomic DNA was digested overnight with 10 units of methylation-sensitive (HpaII, cfoI, SacII and SmaI) and methylation-insensitive (MspI) enzymes. For the assessment of the methylation status of exon 1 of the p16 INK4A gene, 50 ng of digested DNA were ampli®ed by PCR using primers¯anking the restriction sites as previously described (Gonzalez-Zulueta et al., 1995) . Labeling of the PCR products was performed directly with [a- 33 P]dATP during PCR. Five ml of PCR products were electrophoresed on a 5% polyacrylamide gel. Undigested and MspI-digested DNAs were used as controls and were included for every site examined. To rule out the possibility of incomplete digestion, all samples were digested twice with each of the enzymes in independent experiments. PCR ampli®cations from each of the duplicate digests were repeated at least twice to ensure reproducibility of the results.
Fluorescent in situ hybridization (FISH) analysis
Whole imprint preparations were performed by gentle pressing tumoral frozen tissue to silane-coated glass slides, air dried and stored at 7808C until use. For each case analyzed, a slide was stained with Giemsa and the samples used for touch prints were included in order to assess for adequate cellularity and representation of tumor cell populations. Slides were treated for 10 min at room temperature in a 48C nuclei isolation buer (50 mM KCl, 5 mM HEPES pH=8, 10 mM MgSO 4 , 3 mM DTT), then incubated in freezer during 10 min in nuclei isolation buer with TX-100 0.25%, washed with PBS and ®xed for 10 min in paraformaldehyde 4%. Fixation was quenched with Tris 100 nM pH=7.5 during 10 min and the slides were progressively dehydrated in an ethanol series (70%, 90%, 100%). Hybridization was performed with a probe speci®c for the (peri)centromeric region of chromosome 9 (Rocchi et al., 1991) and a 2230 P1 clone containing the entire genomic sequence of p16 INK4A generously provided by Cairns et al. (1995) . The centromeric probe was directly labeled by nick-translation with cyanine 3 dCTP (Amersham) and the 2230 P1 clone was labeled by random priming with biotin-14-dCTP (Life Technologies) according to the instructions of the manufacturer. One hundred and ®fty nanograms of each probe were precipitated with NaAc 0.3 M, 5 mg human cot DNA, 10mg of salmon sperm DNA and two volumes EtOH and resuspended in 10 ml of 50% formamide/10% dextran sulfate/26SSC. The mixture was immediately applied to the touch preparations which were then covered with an 18618 mm coverslip, sealed with rubber cement and left at room temperature for 2 h. Denaturation was performed at 868C for 10 min and the slides were incubated in a moist chamber overnight at 378C. Posthybridization washing was carried out at 458C in 26SSC/50% formamide (365 min) followed by three washes in 0.16SSC at 608C. Detection was performed at 378C using FITC-conjugated avidin for 30 min followed by three washes in 46SSC/0.1% tween 20 at 458C. The slides were counterstained with 4',6-diamidino-2-phenylindole (DAPI) in antifade solution and the preparations observed under an epi¯uorescent microscope (Zeiss Axiophot). Images were collected with a cooled CCD camera (C4880 Hamamatsu) mounted on the epifluorescent microscope. Imprint preparations were imaged using a 6361.25 N.A oil immersion objective and an intermediate magni®cation of 1.256. The exposure time was between 2 and 8 s.
